30 Apr 2013
Today CDDEP is excited to release a new video on antibiotic resistance: Unstoppable Superbugs: Closer Than We Think? Currently, healthcare-associated infections, about 70 percent of which are resistant to at least one drug, contribute to 99,000 deaths each year in the U.S.,
and the problem is getting worse. So what can the concerned public do to help? As
it turns out, there’s a lot we can do.
7 Apr 2013
A number of Extending the Cure studies have highlighted the changing epidemiology of methicillin-resistant S. aureus (MRSA): first, we noted the emergence of community strains (CA-MRSA) and their move into hospitals, where they added to the existing burden of healthcare-associated strains (HA-MRSA).
5 Mar 2013
The latest Morbidity and Mortality Weekly Report (MMWR)
by the US Centers for Disease Control (CDC) addresses the emerging
threat of carbapenem-resistant Enterobacteriaceae (CRE). The MMWR,
featuring a contribution from CDDEP researchers, reports on the rising
prevalence of CREs in US health care facilities and stresses the need
for increased surveillance and “a broader, multi-institutional or
regional approach” to prevent and control infections.
28 Feb 2013
The growth of MRSA-related
hospitalizations was stagnant between 2005 and 2009; Community-associated infections
peak in the summer, likely due to seasonal antibiotic overuse.
4 Feb 2013
The Food and Drug Administration (FDA) is announcing a public hearing to
obtain input on the Limited Population Antimicrobial Drug (LPAD) approval pathway – a potential new mechanims to expedite the development of
drugs, including biological products, for serious or life-threatening
conditions that would address an unmet medical need. The drug’s safety
and effectiveness would be studied in a smaller subpopulation of
patients with more serious manifestations of a condition.
